Take-home naloxone
| Autor: | Thara Kumar, Hans Rosenberg |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Prescription drug
business.industry 030508 substance abuse Pharmacy General Medicine medicine.disease Schedule II 03 medical and health sciences 0302 clinical medicine Naloxone medicine 030212 general & internal medicine Medical emergency Meaning (existential) 0305 other medical science business medicine.drug |
| Zdroj: | Canadian Medical Association Journal. 189:E1192-E1192 |
| ISSN: | 1488-2329 0820-3946 |
| DOI: | 10.1503/cmaj.170600 |
| Popis: | In 2016, naloxone was removed from the federal Prescription Drug List, and the National Association of Pharmacy Regulatory Authorities reclassified the drug as Schedule II, meaning pharmacists can dispense it without prescription.[1][1],[2][2] It is available in commercial formulations, including |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|